|
Market Cap (26-May) $2,158,966,016 (333rd) |
Close (30-Jun) $1.14 |
Volume (30-Jun) 2,606,681 |
Shortsold (5-May) 72,824,861 (5.70%) (40th) |
|
52w High $3.37 |
52w Low $0.88 |
P/E 454.55 |
EPS -0.14 |
MSB released this announcement to the ASX on 26 October 2020, 14:53. The announcement is not marked as price sensitive, and is 19 page(s) in length and 202.52kb in size.
You can view all announcements from MSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, MSB was 9.490% short sold according to ASIC data. It was ranked the 4th most shorted stock on the ASX. It remains ranked 40th as of the latest reported data (05 May 2025).
| Other Recent Announcements from MSB | |
|---|---|
| Change of Director's Interest Notice | 13 June 2023, 8:56 |
| Mesoblast Director Appointed to Strategic Advisory Role | 5 June 2023, 9:41 |
| MSB Reports Q3 Financial Results and Operational Highlights | 26 May 2023, 8:32 |
| Third Quarter Results Presentation | 26 May 2023, 8:26 |
| Appendix 4G and Corporate Governance Statement | 26 October 2020, 14:53 |
| Remestemcel Controlled Study in Crohns & Ulcerative Colitis | 22 October 2020, 9:38 |
| Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment | 13 October 2020, 13:31 |
You must be logged in to post a reply.
Mesoblast 